- ICH GCP
- USA klinikai vizsgálatok nyilvántartása
- Klinikai vizsgálat NCT03546517
Effectiveness of Dry Needling (DNHS Technique) in Patients With Chronic Stroke
Study hypothesis:
The DNHS technique, performed via one session of deep dry needling of myofascial trigger points applied to the biceps brachii, brachialis, flexor digitorum superficialis, flexor digitorum profundus, triceps brachii, extensor digitorum and adductor pollicis muscle is effective for decreasing spasticity and muscle stiffness (both of which are components of hypertonia) as well as for improving the upper limb function of the previously described muscles in patients with chronic cerebral vascular accident (CVA), assessed both post-intervention and after 15 days.
General aims
To analyse the immediate therapeutic effect of the DNHS technique and the effect at 15 days follow-up, for the following variables:
- Spasticity
- Muscle stiffness
- Upper limb function
- Patient perceived quality of life
Materials and methods Population: patients from the province of Zaragoza (Spain) diagnosed with a haemorrhagic or ischemic CVA by a neurologist.
Recruitment strategy: recruitment will take place via the Stroke Association in Aragon (AIDA) [Aragon Stroke Association] in the province of Zaragoza, Spain, seeing as the greater proportion of patients who have suffered a stroke and are in the chronic stage of the illness go to this centre to receive treatment. Thus, this avoids patients having to travel elsewhere for the study. Furthermore, in the case of patients who wish to participate in the study after having received information via third persons or via other means and who are not members of the Association or do not attend the centre on a regular basis, the Association AIDA has offered to allow these people to attend for free, making its facilities available and supporting the development of this study.
A tanulmány áttekintése
Állapot
Körülmények
Beavatkozás / kezelés
Tanulmány típusa
Beiratkozás (Tényleges)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi helyek
-
-
-
Zaragoza, Spanyolország, 50830
- Universidad San Jorge
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Patients who have been diagnosed with a haemorrhagic or ischemic CVA by a neurologist.
- Cognitive level: minimental state examination (MMSE) ≥ 27 points. All patients must have a good cognitive level in order to ensure that they are able to communicate with the professionals involved in the study in order to understand the exercises and thus fulfil the objectives for participation.
- Presence of spasticity ≥1 according to the Modified Modified Ashworth Scale (MMAS) score during the flexion-extension movement of the wrist and elbow in at least one of the muscles of the upper limb evaluated.
- Age: between 30 - 90 years. In this range of age CVA's are more common, according to data from the Spanish Statistical Office.
- Evolution: over 6 months must have passed since the CVA episode. Most of the studies reviewed involve patients who are in the chronic stage of illness. This will ensure that the changes found are due to our intervention and not related to plasticity mechanisms occurring after the injury (this will be considered objectively by performing an assessment at baseline, which will be repeated 1 week later, immediately before and after the dry needling intervention).
Exclusion Criteria:
- Concomitance of degenerative illnesses which can alter the results.
- Presence of fixed contractures: 4 according to the MMAS score
- Suffering from epileptic fits that are not medically controlled.
- Fear of needles.
- No tolerance to pain caused by needling.
- Those unable to commit to attendance.
- Patients who have received treatment with Botulinum Toxin (BTX A) in the 6 months prior to their inclusion in this study, or those who received said medication or another during the study with the aim of decreasing spasticity.
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Kezelés
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Párhuzamos hozzárendelés
- Maszkolás: Kettős
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
---|---|
Kísérleti: Intervention with DNHS technique
Dry needling of biceps brachii, brachialis, flexor digitorum superficialis and flexor digitorum profundus, triceps brachialis, extensor digitorum and adductor pollicis
|
Dry needling of biceps brachii, brachialis, flexor digitorum superficialis and flexor digitorum profundus, triceps brachialis, extensor digitorum and adductor pollicis
Más nevek:
|
Sham Comparator: Sham Dry Needling
Sham Dry needling of biceps brachii, brachialis, flexor digitorum superficialis and flexor digitorum profundus, triceps brachialis, extensor digitorum and adductor pollicis
|
Sham Dry needling of biceps brachii, brachialis, flexor digitorum superficialis and flexor digitorum profundus, triceps brachialis, extensor digitorum and adductor pollicis
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
---|---|---|
Fugl-Meyer Scale
Időkeret: Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Scale measuring Upper Limb Function in stroke patients.
The motor and sensory assessments are scored on a three-point ordinal scale (0 -2) in which a higher score indicates superior results.
The motor assessment measures voluntary limb movement and includes a subscale for the Upper Extremity (33 items; score range, 0-66).
The sensory assessment measures limb sensation.
Sensation is assessed as absent, impaired, or normal for light touch (two items each for Upper Extremity (UE) and Lower Extremity (LE); score range, 0-8) and proprioception (four items each for UE and LE; score range, 0-16) for a total sensory Fugl-Meyer (FM) score of 24.
Fugl-Meyer Assessment (FMA) has shown to have an excellent intra and interrater reliability (0.89-0.99).
The estimated minimal clinical important difference (MCID) of the UE-FM scores ranged from 4.25 to 7.25 points .
|
Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
---|---|---|
Modified Modified Ashworth Scale
Időkeret: Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Scale measuring Spasticity/Hypertonia.
This scale ranges from 0 to 4 points for each muscle assessed, where 0 is no hypertonia/spasticity and 4 is the highest hypertonia/spasticity.
|
Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Electromyography (EMG)
Időkeret: Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Neurophysiological measurements (electromyographic measurements).
The amount of electrical activity will be measured quantitatively, from 0 to an undefined value (depending on every muscle´s activity)
|
Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Tonometry (measurement of muscle tone with a device)
Időkeret: Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Muscle stiffness or muscle tone.
This device register different parameters like frequency, oscillation, etc that are related to tone, and start from 0 to an undefined number (depending on every muscle).
It is a quantitative measurement.
|
Change between baseline (immediately before intervention) and post intervention (immediately after intervention). Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Quality of Life (Euro QoL5D)
Időkeret: Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Quality of Life.
This scale measures quality of life.
Description: This is a measure of self-reported health outcomes.
It consists of two parts: a descriptive system (Part I) and a visual analogue scale (VAS) (Part II).
Part I of the scale consists of 5 single-item dimensions including: mobility, self care, usual activities, pain/discomfort, and anxiety/depression.
Each dimension has a 3 point response scale, ranging from worst imaginable health state to best imaginable health state.
Scoring/Interpretation: Descriptive data from the 5 dimensions of Part I can be used to generate a health-related quality of life profile for the subject.
Part II is scored from 0 (worst health state imaginable) to 100 (best health state imaginable).
|
Change between baseline (immediately before intervention) and follow-up at 2 weeks after intervention
|
Együttműködők és nyomozók
Szponzor
Publikációk és hasznos linkek
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Tényleges)
A tanulmány befejezése (Tényleges)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
- Szív-és érrendszeri betegségek
- Érrendszeri betegségek
- Cerebrovaszkuláris rendellenességek
- Agyi betegségek
- Központi idegrendszeri betegségek
- Idegrendszeri betegségek
- Neurológiai megnyilvánulások
- Mozgásszervi betegségek
- Izombetegségek
- Neuromuszkuláris megnyilvánulások
- Izom-hipertónia
- Stroke
- Izomgörcsösség
Egyéb vizsgálati azonosító számok
- DNHS_stroke
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
IPD terv leírása
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .
Klinikai vizsgálatok a Stroke
-
Institut National de la Santé Et de la Recherche...Befejezve
Klinikai vizsgálatok a Dry Needling
-
Youngstown State UniversityToborzás
-
Franklin Pierce UniversityNewcastle University; Concord HospitalBefejezve
-
University GhentToborzásFejfájás | Mobilitás korlátozása | Nyakfájdalom, hátsóBelgium
-
Universidad Rey Juan CarlosBefejezve
-
University of Nevada, Las VegasBefejezveDerékfájás, mechanikaiEgyesült Államok
-
Universiteit AntwerpenBefejezveOsteoarthritis, térd
-
Keller Army Community HospitalBefejezveMobilitás korlátozásaEgyesült Államok
-
Texas Woman's UniversityAktív, nem toborzóVállfájdalom | Dry NeedlingEgyesült Államok
-
Universidad de ZaragozaBefejezveFeszült típusú fejfájás | Dry NeedlingSpanyolország
-
Emily Slaven, PT, PhDMount St Joseph UniversityBefejezveIzomgyengeség | Trigger pontEgyesült Államok